Roundtable Discussion: Communicating the Importance of Non-Coding RNA Therapeutics Compared to mRNAs to Investors
Time: 2:15 pm
day: Day Two
- Outlining the advantages of different emerging non-coding RNAs in comparison to mRNAs
- Unravelling different approaches of communicating the importance of non-coding RNA therapeutics to the industry
- How can more interest be raised for investors?